A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia

Blood

Volumn 91, Issue 9, 1998, Pages 3401-3413

  Legras, S ^b   Gunthert U ^b   Stauder, R ^b   Curt, F ^b   Oliferenko, S ^b   Kluin Nelemans, H C ^b   Marie, J P ^b   Proctor, S ^b   Jasmin, C ^b   Smadja Joffe, F ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; COMPLEMENTARY DNA; GLYCOPROTEIN; HERMES ANTIGEN; MONOCLONAL ANTIBODY; RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GRANULOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 2642671976     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3401.3401_3401_3413     Document Type: Article

References (48)

1. Günthert U: CD44: CD44 in malignant disorders. Curr Top Microbiol Immun 213:271, 1996
2. Günthert U: CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immun 184:47, 1993
3. Screaton GR, Bell MV, Jackson DG: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Ac Sci USA 89:12160, 1993
4. Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T, Kincade PW: Monoclonal antibodies to Pgp-1/CD44 block lymphohematopoiesis in long-term bone-marrow cultures. J Exp Med 171:477, 1990
5. +. Blood 80:429, 1992
6. Morimoto K, Robin E, Le Bousse-Kerdilès MC, Li Y, Clay D, Jasmin C, Smadja-Joffe F: CD44 mediates hyaluronan binding by human myeloid KG1a and KG1 cells. Blood 83:657, 1994
7. Smadja-Joffe F, Legras S, Girard N, Li Y, Delpech B, Morimoto K, Le Bousse-Kerdilès C, Clay D, Jasmin C, Lévesque JP: CD44 and hyaluronan-binding by human myeloid cells. Leuk Lymph 21:407, 1996
8. Legras S, Lévesque JP, Charrad R, Morimoto K, Le Bousse-Kerdilès MC, Clay D, Jasmin C, Smadja-Joffe F: CD44-mediated adhesiveness of human hemopoietic progenitors to hyaluronan is modulated bycytokines. Blood 89:1905, 1997
9. Underhill C: CD44: The hyaluronan receptor. J Cell Sci 103:293, 1992
10. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990
11. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with the extracellular matrix. Adv Immunol 54:271, 1993
12. Del Rosso M, Capelletti R, Dini G, Fibbi G, Vannucchi S, Chiarugi V, Guazzelli C: Involvement of glycosaminoglycans in detachment of early myeloid precursors from bone-marrow cells. Biochim Biophys Acta 676:129, 1981
13. Gallagher JT, Spooncer E, Dexter TM: Role of the extracellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J Cell Sci 63:155, 1983
14. Gordon MY: Extracellular matrix of the marrow microenvironment. Br J Haematol 70:1, 1988
15. Smadja-Joffe F, Moczar M, Le Bousse-Kerdilès MC, Delpech B, Leibovitch MP, Dufour F, Jasmin C: Increased synthesis of extracellular spleen glycosaminoglycans in an experimental myeloproliferative syndrome. Leukemia 6:1011, 1992
16. Koshiishi I, Shizari M, Underhill CB: CD44 can mediate the adhesion of platelets to hyaluronan. Blood 84:390, 1994
17. Culty M, O'Mara TE, Underhill CB, Yeager H, Swartz RP: Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages. J Leukoc Biol 56:605, 1994
18. Lund-Johansen F, Terstappen LWMM: Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 54:47, 1993
19. Ghaffari S, Dougherty GJ, Lansdorp PM, Eaves AC, Eaves CJ: Differentiation-associated changes in CD44 isoform expressing during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 86:2976, 1995
20. Kansas GS, Muirhead MJ, Dailey MO: Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 76:2483, 1990
21. Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC: Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 75:589, 1990
22. Mackay CR, Terpe HJ, Stauder R, Martson WL, Stark H, Günthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71, 1994
23. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M: Participation in normal immune responses of a metastasisinducing splice variant of CD44. Science 257:682, 1992
24. Levesque MC, Haynes BF: In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol 156:1557, 1996
25. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109, 1994
26. Koopman G, Heider K, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897, 1993
27. Stauder R, Eisterer W, Thaler J, Günthert U: CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor. Blood 85:2885, 1995
28. Stauder R, Günthert U: CD44 isoforms: Impact on lymphocyte activation and differentiation. Immunologist 3:26, 1995
29. Salles G, Zain M, Jiang W, Boussiotis VA, Shipp MA: Alternatively spliced CD44 transcripts in diffuse large cell lymphomas characterization and comparison with normal activated B cells and epithelial malignancies. Blood 82:3539, 1993
30. Kryworuckho M, Diaz-Mitoma F, Kumar A: CD44 isoforms containing exons v6 and v7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells. Immunology 86:41, 1995
31. Khaldoyanidi S, Schnabel D, Föhr N, Zöller M: Functional activity of CD44 isoforms in haemopoiesis of the rat. Br J Haematol 96:31, 1997
32. Stauder R, van Driel M, Schwarzler C, Thaler, Lokhorst ED, Kreuser ED, Bloem AC, Günthert U, Eisterer W: Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 88:3101, 1996
33. Ghaffari S, Dougherty GJ, Eaves AC, Eaves CJ: Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. Leukemia 10:1773, 1996
34. Bennett JM, Catosvsky D, Daniel MT: Proposals for the classification of acute leukemias. Br J Haematol 33:451, 1976
35. Bennett JM, Catosvsky D, Daniel MT: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Int Med 103:626, 1985
36. Büchner T: Treatment of adult acute leukemia. Curr Opin Oncol 9:18, 1997
37. Terstappen LWMM, Köneman S, Safford M, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wormann B: Flow cytometric characterization of acute myeloid leukemia. Part I. Significance of light scattering properties. Leukemia 5:315, 1991
38. Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457, 1958
39. Cox DR: Regression models and life tables. J R Stat Soc B 34:187, 1972
40. Khaldoyanidi S, Achtnich M, Hehlmann R, Zöller M: Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: Inverse correlation between expression and tumor progression. Leuk Res 20:839, 1996
41. Kuijpers TW, Tool ATJ, van der School CE, Ginsel LA, Onderwater JJM, Roos D, Verhoeven AJ: Membrane surface antigen expression on neutrophils: A reappraisal of the use of surface markers for neutrophil activation. Blood 78:1105, 1991
42. Youssef PP, Mantzioris BX, Roberts-Thomson PJ, Ahern MJ, Smith MD: Effects of ex vivo manipulation on the expression of cell adhesion molecules on neutrophils. J Immun Methods 186:217, 1995
43. Jackson DD, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673, 1995
44. Fenaux P, Chomienne C: Biology and treatment of acute promyelocytic leukemia. Curr Opin Oncol 8:3, 1996
45. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade P: Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182:419, 1995
46. Lesley J, English N, Perschl A, Gregoroff J, Hyman R: Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182:431, 1995
47. Ghaffari S, Dougherty GJ, Eaves AC, Eaves CJ: Diverse effects of anti-CD44 antibodies on the stromal cell-mediated support of normal but not leukaemic (CML) haemopoiesis in vitro. Br J Haematol 97:22, 1997
48. Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D, Bradstock K, Enno A, Wolf MM, Fox R, Cobcroft R, Hermann R, van Der Weyden M, Lowenthal RM, Page F, Garson OM, Juneja S: A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 87:1710, 1996